Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials.
Lenis, Andrew T
Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials. [electronic resource] - The Journal of urology 01 2018 - 43-52 p. digital
Publication Type: Journal Article; Review
1527-3792
10.1016/j.juro.2017.04.092 doi
Antineoplastic Agents--therapeutic use
Cancer Vaccines--therapeutic use
Carcinoma, Renal Cell--drug therapy
Chemotherapy, Adjuvant--trends
Clinical Trials as Topic
Evidence-Based Medicine
Humans
Immunotherapy--trends
Kidney Neoplasms--drug therapy
Research Design
Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials. [electronic resource] - The Journal of urology 01 2018 - 43-52 p. digital
Publication Type: Journal Article; Review
1527-3792
10.1016/j.juro.2017.04.092 doi
Antineoplastic Agents--therapeutic use
Cancer Vaccines--therapeutic use
Carcinoma, Renal Cell--drug therapy
Chemotherapy, Adjuvant--trends
Clinical Trials as Topic
Evidence-Based Medicine
Humans
Immunotherapy--trends
Kidney Neoplasms--drug therapy
Research Design